UY29555A1 - Nuevos compuestos quimicos - Google Patents

Nuevos compuestos quimicos

Info

Publication number
UY29555A1
UY29555A1 UY29555A UY29555A UY29555A1 UY 29555 A1 UY29555 A1 UY 29555A1 UY 29555 A UY29555 A UY 29555A UY 29555 A UY29555 A UY 29555A UY 29555 A1 UY29555 A1 UY 29555A1
Authority
UY
Uruguay
Prior art keywords
chemical compounds
new chemical
hyak3
methods
relates
Prior art date
Application number
UY29555A
Other languages
English (en)
Inventor
Kevis J Duffy
Deping Chai
Mariela Colon
Duke M Fitch
Neil W Johnson
Sarah Rae King
Antony N Shaw
Rosanna Tedesco
Kenneth Wiggall
Michael N Zimmerman
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of UY29555A1 publication Critical patent/UY29555A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a compuestos recién identificados para inhibir las proteínas hYAK3 y a métodos para tratar enfermedades asociadas con la actividad hYAK3.
UY29555A 2005-05-23 2006-05-19 Nuevos compuestos quimicos UY29555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68375205P 2005-05-23 2005-05-23

Publications (1)

Publication Number Publication Date
UY29555A1 true UY29555A1 (es) 2006-11-30

Family

ID=37452631

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29555A UY29555A1 (es) 2005-05-23 2006-05-19 Nuevos compuestos quimicos

Country Status (8)

Country Link
US (1) US20090203692A1 (es)
EP (1) EP1885362A4 (es)
JP (1) JP2008545690A (es)
AR (1) AR054048A1 (es)
PE (1) PE20070006A1 (es)
TW (1) TW200716579A (es)
UY (1) UY29555A1 (es)
WO (1) WO2006127458A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070083A1 (es) 2005-06-08 2007-01-27 Smithkline Beecham Corp (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona
JP2009528386A (ja) * 2006-03-02 2009-08-06 スミスクライン・ビーチャム・コーポレイション Ｐｉ３キナーゼ阻害剤として用いるためのチアゾロン
CN103804312B (zh) * 2014-02-17 2016-04-20 四川百利药业有限责任公司 一类氮杂环化合物及其制备方法和用途
CN107721915A (zh) * 2017-11-12 2018-02-23 刘磊 一种氯羟吡啶毒性杂质dcal的制备及纯化方法
JP7311520B2 (ja) * 2018-01-18 2023-07-19 エフ エム シー コーポレーション スルフェントラゾンの合成のための方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1567112B1 (en) * 2002-11-22 2008-10-15 Smithkline Beecham Corporation THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
JP2007523957A (ja) * 2004-02-25 2007-08-23 スミスクライン・ビーチャム・コーポレイション 新規化学化合物
EP1771443B1 (en) * 2004-07-01 2009-01-07 F.Hoffmann-La Roche Ag Quinoline thiazolinones with cdk-1 antiproliferative activity
KR100866298B1 (ko) * 2004-07-01 2008-10-31 에프. 호프만-라 로슈 아게 티아졸리논 비치환된 퀴놀린
US7241893B2 (en) * 2004-09-17 2007-07-10 Hoffman-La Roche Inc. Thiazolinone 2-substituted quinolines
US7253285B2 (en) * 2004-09-17 2007-08-07 Hoffmann-La Roche Inc. Thiazolinone 4-monosubstituted quinolines
JP2009528386A (ja) * 2006-03-02 2009-08-06 スミスクライン・ビーチャム・コーポレイション Ｐｉ３キナーゼ阻害剤として用いるためのチアゾロン

Also Published As

Publication number Publication date
EP1885362A2 (en) 2008-02-13
JP2008545690A (ja) 2008-12-18
US20090203692A1 (en) 2009-08-13
WO2006127458A3 (en) 2007-05-18
AR054048A1 (es) 2007-05-30
EP1885362A4 (en) 2010-09-22
PE20070006A1 (es) 2007-01-31
TW200716579A (en) 2007-05-01
WO2006127458A2 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
LTC1891101I2 (lt) Sklerostiną surišantys agentai
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
ECSP055808A (es) Nuevos compuestos quimicos
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DK1879623T3 (da) Genterapi til rygmarvssygdomme
HN2011000876A (es) Inhibidores de las enzimas de proteina cinaza activadas por mitogeno p38
BRPI0513310A (pt) análogos de tetrapeptìdeo
EA200971077A1 (ru) Гетероциклические модуляторы киназы
ECSP088782A (es) Compuestos nuevos
ATE540949T1 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
MX2009011210A (es) Inhibidores de mcl1 de indol 7-no sustituido.
TW200716132A (en) Novel chemical compounds
DE502004003364D1 (de) Fördersystem für werkstücke oder gegenstände
ATE518867T1 (de) Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheiten
ATE496913T1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
FI20055534A0 (fi) Menetelmä verkkosuolen valmistamiseksi
UY29555A1 (es) Nuevos compuestos quimicos
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen
CR8552A (es) Proceso para la preparacion de inhibidores de triptasa